BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2021
View Archived Issues
Enobosarm confers clinical benefit in patients with AR+/ER+ metastatic breast cancer
Read More
ChemoCentryx describes new PD-1/PD-L1 interaction inhibitors
Read More
Stanford University presents new anticancer peptides
Read More
New antibacterials discovered at Wockhardt
Read More
TroBio Therapeutics identifies new tropomyosin alpha-3 chain inhibitors
Read More
AAV9 encoding NPC intracellular cholesterol transporter 1 synthesized at StrideBio
Read More
TRPV1 antagonist SAF-312 reduces pain after photorefractive keratectomy
Read More
Natural language processing identifies impact of diazoxide choline on Prader-Willi syndrome
Read More
Anti-CD3 DARPin T-cell engager is active only in the tumor microenvironment
Read More
IMV to initiate phase Ib study of maveropepimut-S in breast cancer
Read More
Checkmate and Regeneron enter agreement to evaluate vidutolimod plus cemiplimab
Read More
Diffusion reports final data from phase Ib study of TSC in hospitalized COVID-19 patients
Read More
Key interim analysis findings from phase Ia/Ib monotherapy study of CUE-101 in HNSCC
Read More
G1 Therapeutics initiates phase II PRESERVE 4 study of trilaciclib in NSCLC
Read More
First patient dosed in phase I/II study of CBX-12 in advanced or metastatic refractory solid tumors
Read More
GBR-830 shows improvement at 16 weeks in patients with moderate to severe atopic dermatitis
Read More
Novel progression risk tissue markers in premalignant cervical lesions
Read More
Ascendis reports 58-week data from phase II OLE study of TransCon PTH in hypoparathyroidism
Read More
FDA authorizes Pfizer and BioNTech's COVID-19 vaccine for adolescents aged 12-15 years
Read More
Gavo-cel shows promising phase I/II results in patients with mesothelin-overexpressing solid tumors
Read More
Hamlet Pharma reports dose-escalation data on Alpha-1H in bladder cancer
Read More
Phase I trial of Ampion in long COVID receives IRB approval
Read More
Enrollment opens in phase II study of BA-3011 for metastatic NSCLC
Read More
New phase I trial evaluates PBCAR-19B in CD19-expressing malignancies
Read More
SARS-CoV-2 vaccines make progress in the young, the old, the in-between
Read More
